Search
Displaying 4 news results
-
Here's a new way to raise money for medical research: Selling bonds to Wall Street
Want to advance hard-to-fund medical research? Get Wall Street to pay for it.
-
A Retinal Research Nonprofit Paves the Way for Commercializing Gene Therapies
AN EMERGING, vision-restoring gene therapy for a devastating retinal disease is poised for Food and Drug Administration (FDA) approval. If it gets the regulatory nod, it will be the first gene therapy to receive FDA approval for the eye or an inherited condition.
-
The Challenge Continues: FFB Chairman Gordon Gund is Interviewed on CNBC
In a recent interview with CNBC’ s Brian Sullivan, during a tech-investor conference in Nantucket, Gordon explained why this is such a crucial time in retinal-research history.
-
FFB Chairman, Gordon Gund, Interviewed on Forbes.com
The Foundation’s chairman and co-founder, Gordon Gund is interviewed on Forbes.com
